Factors Determining the Efficacy of Botulinum Toxin for Arm Tremor in Dystonia

PHASE4RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

May 30, 2027

Study Completion Date

May 30, 2027

Conditions
Dystonic Tremor Syndrome
Interventions
DIAGNOSTIC_TEST

Polymyography

We will measure muscle activity using surface electromyography and tremor using inertial measurement units while subjects perform rest, posturing and kinetic tasks.

DIAGNOSTIC_TEST

Muscle ultrasound

We will obtain B-mode images and videos of upper extremity muscles of the most affected upper extremity.

DIAGNOSTIC_TEST

(Functional) magnetic resonance imaging

Subjects will undergo (f)MRI scanning involving concurrent electromyography, accelerometry and functional magnetic resonance imaging.

DIAGNOSTIC_TEST

Clinical assessment

We will assess tremor and dystonia severity using clinical scales.

DIAGNOSTIC_TEST

Questionnaires

We will collect patient-reported outcomes.

DRUG

botulinum toxin injection (BTX A)

Three consequetive botulinum toxin injections of the upper extremities

Trial Locations (3)

6525 EN

RECRUITING

Donders Centre for Cognitive Neuroimaging, Nijmegen

6525 GA

RECRUITING

Radboud University Medical Center, Nijmegen

6532 SZ

RECRUITING

Canisius-Wilhelmina Ziekenhuis, Nijmegen

All Listed Sponsors
collaborator

Canisius-Wilhelmina Hospital

OTHER

collaborator

Donders Centre for Cognitive Neuroimaging

OTHER

lead

Radboud University Medical Center

OTHER

NCT06411028 - Factors Determining the Efficacy of Botulinum Toxin for Arm Tremor in Dystonia | Biotech Hunter | Biotech Hunter